Zhejiang East-Asia Pharmaceutical Stock Forum

Despite positive earnings growth, the company's low P/E ratio indicates investor skepticism about future growth. The market-matching earnings outlook isn't boosting its P/E as expected, hinting at potential unseen threats to earnings. Investors appear to foresee future earnings volatility.